Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

NCT05373108 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Allograft Vasculopathy

Interventions

DRUG: Macitentan

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]